Hybrid ligand 10, a silylated analogue of the antiangiogenic peptide H-ATWLPPR-OH, a neuropilin-1 receptor (NRP1) antagonist involved in cancer [40], was selected as the second ligand. This evidence concerns the gene NRP1 and cancer.